FIGS, Inc. (NYSE:FIGS ) Goldman Sachs 32nd Annual Global Retailing Conference 2025 September 3, 2025 3:55 PM EDT Company Participants Sarah Oughtred - Chief Financial Officer Catherine Spear - Co-Founder, CEO & Director Conference Call Participants Brooke Roach - Goldman Sachs Group, Inc., Research Division Presentation Brooke Roach Research Analyst Good afternoon, and welcome to this next session of the GS 32nd Annual Global Retailing Conference. My name is Brooke Roach, and I cover the apparel brands and softline sector here at Goldman, and I'm very happy to introduce our next session with FIGS.
FIGS, Inc. delivered strong Q2 results with U.S. core scrubs demand rebounding and solid OpEx leverage, driving improved profitability. Guidance was raised for both revenue and margin, but management remains cautious on 2H25 due to tariffs and reduced promotional activity. International expansion is contributing meaningfully, but US growth remains the key driver amid ongoing headwinds in non-scrubwear and Canada.
FIGS, Inc. (NYSE:FIGS ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Catherine Eva Spear - Co-Founder, CEO & Director Sarah Oughtred - Chief Financial Officer Thomas D. Shaw - Senior Vice President of Investor Relations Conference Call Participants Angus Kelleher-Ferguson - Barclays Bank PLC, Research Division Brian William Nagel - Oppenheimer & Co. Inc., Research Division Brooke Siler Roach - Goldman Sachs Group, Inc., Research Division Dana Lauren Telsey - Telsey Advisory Group LLC John David Kernan - TD Cowen, Research Division Matthew Butler Koranda - ROTH Capital Partners, LLC, Research Division Nathaniel Jay Feather - Morgan Stanley, Research Division Rakesh Babarbhai Patel - Raymond James & Associates, Inc., Research Division Operator Good afternoon.
While the top- and bottom-line numbers for Figs (FIGS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Figs (FIGS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago.
From a technical perspective, FIGS, Inc. (FIGS) is looking like an interesting pick, as it just reached a key level of support. FIGS's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Figs (FIGS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
FIGS showed modest U.S. growth in 1Q25, but inconsistent quarterly trends make it too early to call a sustained recovery. International sales remain a growth driver, but expansion is decelerating and comps will get tougher as the business scales. Management's strategy to absorb tariffs via cost efficiencies is sound, but margin pressure persists and guidance was lowered.
FIGS, Inc. (NYSE:FIGS ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder and Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Matt Koranda - ROTH Capital Brooke Roach - Goldman Sachs Rick Patel - Raymond James Brian Nagel - Oppenheimer Dana Telsey - Telsey Group Nathan Feather - Morgan Stanley Lorraine Hutchinson - Bank of America Operator Good afternoon. Thank you for attending today's FIGS First Quarter Fiscal 2025 Earnings Conference Call.
Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Figs (FIGS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.
Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO.